BioInfoExperts LLC
BioInfoExperts specializes in pathogen genomics, molecular research, and software development with a focus on pathogen transmission, evolution, and bioinformatics. They develop and utilize proprietary software like FoxSeq to analyze pathogen genetic data, supporting research, healthcare, and industry applications. The company is committed to advancing infectious disease understanding and control through innovative genomics and bioinformatics solutions.
Industries
Nr. of Employees
small (1-50)
BioInfoExperts LLC
UF Sid Martin Bio-incubator, Alachua, Florida
Products
Cloud-based pathogen sequencing analytics platform
A hosted analytics platform that automates processing of sequencing data, provides interactive visualizations, and integrates pathogen genetics with clinical metadata and contact-tracing workflows in a secure environment.
Cloud-based pathogen sequencing analytics platform
A hosted analytics platform that automates processing of sequencing data, provides interactive visualizations, and integrates pathogen genetics with clinical metadata and contact-tracing workflows in a secure environment.
Services
Collaborative, end-to-end support including experimental design, sequencing data generation, computation, visualization, and reporting tailored to pathogen targets.
Wet-lab services at a molecular research laboratory including nucleic acid extraction, quantitation, PCR, and high-throughput sequencing on short- and long-read platforms.
Hosted analytics that automatically process sequence data and present interactive visualizations and searchable results via a private web interface; implemented with secure, compliance-aware practices.
Operational integration that links sequencing outputs with clinical metadata and contact-tracing data to support near real-time surveillance and infection control.
Consultation on experimental approaches and assistance with manuscript and grant preparation for pathogen genomics research.
Collaborative, end-to-end support including experimental design, sequencing data generation, computation, visualization, and reporting tailored to pathogen targets.
Wet-lab services at a molecular research laboratory including nucleic acid extraction, quantitation, PCR, and high-throughput sequencing on short- and long-read platforms.
Hosted analytics that automatically process sequence data and present interactive visualizations and searchable results via a private web interface; implemented with secure, compliance-aware practices.
Operational integration that links sequencing outputs with clinical metadata and contact-tracing data to support near real-time surveillance and infection control.
Consultation on experimental approaches and assistance with manuscript and grant preparation for pathogen genomics research.
Expertise Areas
- Pathogen genomics
- Genomic epidemiology and outbreak analysis
- Bioinformatics platform development
- Cloud-based analytics and secure deployments
Key Technologies
- Next-generation sequencing (short- and long-read)
- Whole genome sequencing
- Metagenomic sequencing
- RNA sequencing (RNA-Seq)
News & Updates
Quantifying DNA point mutations in commercially available AAV reporter vectors.
Awarded $4 million to provide genomic sequencing of COVID-19 as part of a $500 million initiative.
Discussion on cybersecurity protocols ensuring compliance of BIE's technologies.
Entering gene therapy manufacturing industry, focusing on viral vector-based products like rAAVs.
Discussion about breakthrough technologies by Dr. Chenzhong Li and Susanna Lamers.
Funding for whole pathogen genome sequencing and analysis of up to 35 de-identified samples.
Quantifying DNA point mutations in commercially available AAV reporter vectors.
Awarded $4 million to provide genomic sequencing of COVID-19 as part of a $500 million initiative.
Discussion on cybersecurity protocols ensuring compliance of BIE's technologies.
Entering gene therapy manufacturing industry, focusing on viral vector-based products like rAAVs.
Discussion about breakthrough technologies by Dr. Chenzhong Li and Susanna Lamers.
Funding for whole pathogen genome sequencing and analysis of up to 35 de-identified samples.